🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 13 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Arkansas

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

12
Recruiting now
17
Studies tracked
Arkansas
Selected state
Recruiting Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc. · started 2024-03-19
Alabama · Arkansas · California · Colorado · Florida · Georgia · Indiana · Kentucky
NCT04781140 on ClinicalTrials.gov ↗
Starting soon Phase 3
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Kallyope Inc. · started 2026-09
Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia · Idaho
NCT07816367 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
AstraZeneca · started 2023-08-24
Alabama · Arizona · Arkansas · California · Georgia · Maryland · Massachusetts · Michigan
NCT06023589 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight, Chronic Weight Management, Type2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics · started 2026-07-17
Alabama · Arizona · Arkansas · California · Connecticut · Florida · Georgia · Idaho
NCT07654374 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2024-04-03
Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana · Kentucky
NCT06312137 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
AbbVie · started 2023-12-11
Arizona · Arkansas · California · Colorado · Florida · Indiana · Massachusetts · Minnesota
NCT05995353 on ClinicalTrials.gov ↗
Active
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
Tachycardia, Ventricular, Arrhythmia, Ventricular
Boston Scientific Corporation · started 2021-07-20
Arizona · Arkansas · Florida · Georgia · Kentucky · Minnesota · New Jersey · New York
NCT04798768 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Extensive-Stage Small Cell Lung Cancer
Bristol-Myers Squibb · started 2025-02-25
Alabama · Arkansas · Florida · Georgia · Illinois · Minnesota · New Mexico · North Carolina
NCT06646276 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. · started 2020-11-23
Arkansas · California · Florida · Illinois · Missouri · North Carolina · Ohio · Texas
NCT04626674 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
AstraZeneca · started 2024-04-12
Alabama · Arizona · Arkansas · California · Colorado · Florida · Georgia · Illinois
NCT06307652 on ClinicalTrials.gov ↗
Active
CHAMPION-AF Clinical Trial
Atrial Fibrillation, Stroke, Bleeding
Boston Scientific Corporation · started 2020-10-15
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia
NCT04394546 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Diffuse Large B-Cell Lymphoma
Genmab · started 2023-02-08
Arizona · Arkansas · California · Colorado · Florida · Hawaii · Illinois · Indiana
NCT05578976 on ClinicalTrials.gov ↗
Recruiting Phase 3
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG · started 2024-10-15
Arizona · Arkansas · California · Florida · Georgia · Illinois · Louisiana · Maryland
NCT06641089 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals · started 2025-05-30
Arizona · Arkansas · Colorado · Connecticut · Florida · Georgia · Kentucky · Louisiana
NCT06784752 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer · started 2026-01-30
Arkansas · California · Colorado · Florida · New Jersey · New York · Oregon · Texas
NCT07227298 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
UCB Biopharma SRL · started 2021-12-07
Arizona · Arkansas · California · Connecticut · District of Columbia · Florida · Hawaii · Idaho
NCT05077904 on ClinicalTrials.gov ↗
Active
SIMPLAAFY Clinical Trial
Atrial Fibrillation, Stroke, Bleeding
Boston Scientific Corporation · started 2024-10-01
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT06521463 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 102 Florida · 94 Illinois · 59 Georgia · 53 Arizona · 50 Colorado · 50 Texas · 40 New York · 37 Alabama · 33 Connecticut · 32 Massachusetts · 31 Michigan · 28 Ohio · 28 Indiana · 25 North Carolina · 23 Maryland · 21

Browse by condition

Breast Cancer · 5 Advanced Solid Tumor · 4 Obesity · 4 Chronic Lymphocytic Leukemia · 3 Ovarian Cancer · 3 Non-small Cell Lung Cancer · 3 Ulcerative Colitis · 3 Crohn's Disease · 3 Diffuse Large B-Cell Lymphoma · 3 Small Lymphocytic Lymphoma · 2 Urinary Bladder Neoplasms · 2 Marginal Zone Lymphoma · 2 Multiple Myeloma · 2 Pulmonary Embolism · 2 Bladder Cancer · 2 Small Cell Lung Cancer · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/arkansas (Accessed: 13 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.